ExThera Medical’s Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100) is the first and only commercially available pathogen agnostic adsorption therapy, granted EUA to treat COVID-19 by the FDA in the United States. Seraph 100 has been used to treat over 1,000 patients worldwide most of whom have suffered from severe or critical illness due to COVID-19. A Prospective Multicenter RCT is now underway to demonstrate safety and efficacy.